Hopes are rising that Bayer’s blood-thinning pill, Rivaroxaban, could eventually become a standard treatment for preventing heart attacks, pulmonary embolisms and strokes.
Tens of thousands of Irish people might some day take it following surgery or to prevent blood clots from forming. EU regulators recommended approval of Rivaroxaban last month. Final approval from the European Commission is expected within months.
Henrik Wulff, managing director of Bayer Ltd in Ireland, said Rivaroxaban would ‘‘revolutionise...
Subscribe from just €1 for the first month!
All Digital Access + eReader
Unlimited Access for 1 Month
Then €19.99 a month after the offer period.
€149 For the 1st Year
Unlimited Access for 1 Year
90 Day Pass
Get a Business Account for you and your team